Year-end Sale % OFF 
Abstract
The invention relate to 1, 2-dihydroazete-3-methyl ester and a series of derivatives, which can be used to treat cardiovascular diseases and hepatitis c virus (HCV). This research mainly describe a synthesis route of the key intermediate for synthetizing Forskolin and HCV NS5B inhibitors. The synthesis routes is mainly consist of three steps of acylation, replacement and hydrolysis. This synthesis route provides some valuable references and experimental basis for the synthesis of Forskolin and HCV NS5B inhibitors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IOP Conference Series: Earth and Environmental Science
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
